EMA offers insights on when biologics qualify as new active substances
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesBiotechnologyEuropeProduct LifecycleRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesBiotechnologyEuropeProduct Lifecycle